Evidence map›Paper›PMID 36033437›Full record

ArticleFrontiers in oncology2022

Estimation risk of lymph nodal invasion in patients with early-stage cervical cancer: Cervical cancer application.

Benedetta Guani, Thomas Gaillard, Ly-Ann Teo-Fortin, Vincent Balaya, Anis Feki, Xavier Paoletti, Patrice Mathevet, Marie Plante, Fabrice Lecuru

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Benedetta GuaniDepartment of Gynecology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
Thomas GaillardDepartment of Gynecology, Institut Curie, Paris, France.
Ly-Ann Teo-FortinFaculty of Medicine, Laval University of Quebec, Quebec, QC, Canada.
Vincent BalayaDepartment of Gynecology and Obstetrics, FOCH Hospital, Suresnes, France.
Anis FekiDepartment of Gynecology, Hopital Fribourgeois (HFR), Fribourg, Switzerland.
Xavier PaolettiDepartment of Statistics, Institut Curie, Paris, France.
Patrice MathevetDepartment of Gynecology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
Marie PlanteFaculty of Medicine, Laval University of Quebec, Quebec, QC, Canada.
Fabrice LecuruDepartment of Gynecology, Institut Curie, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Lymph node status is a major prognostic factor in early-stage cervical cancer. Predicting the risk of lymph node metastasis is essential for optimal therapeutic management. The aim of the study was to develop a web-based application to predict the risk of lymph node metastasis in patients with early-stage (IA1 with positive lymph vascular space invasion, IA2 and IB1) cervical cancer. Materials and methods: We performed a secondary analysis of data from two prospective multicenter trials, Senticol 1 and 2 pooled together in the training dataset. The histological risk factors were included in a multivariate logistic regression model in order to determine the most suitable prediction model. An internal validation of the chosen prediction model was then carried out by a cross validation of the 'leave one out cross validation' type. The prediction model was implemented in an interactive online application of the 'Shinyapp' type. Finally, an external validation was performed with a retrospective cohort from L'Hôtel-Dieu de Québec in Canada. Results: Three hundred twenty-one patients participating in Senticol 1 and 2 were included in our training analysis. Among these patients, 280 did not present lymph node invasion (87.2%), 13 presented isolated tumor cells (4%), 11 presented micrometastases (3.4%) and 17 macrometastases (5.3%). Tumor size, presence of lymph-vascular space invasion and stromal invasion were included in the prediction model. The Receiver Operating Characteristic (ROC) Curve from this model had an area under the curve (AUC) of 0.79 (95% CI [0.69- 0.90]). The AUC from the cross validation was 0.65. The external validation on the Canadian cohort confirmed a good discrimination of the model with an AUC of 0.83. Discussion: This is the first study of a prediction score for lymph node involvement in early-stage cervical cancer that includes internal and external validation. The web application is a simple, practical, and modern method of using this prediction score to assist in clinical management.

Indexed as

cervical cancercervical cancer web applicationearly-stage cervical cancergynecological cancerlymph nodal status

Identifiers

PMID36033437
PMCPMC9413841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.